Identification of differentially expressed genes in human prostate cancer using subtraction and microarray

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Prostate cancer research requires identification of specific genes for diagnostic and therapeutic advancements.
• Current methods for gene discovery can be enhanced by combining subtractive hybridization with high-throughput screening.

Purpose of the Study:

• To identify novel human prostate cancer- and tissue-specific genes.
• To characterize the expression profiles of newly identified genes in prostate tissues and tumors.
• To evaluate the potential of these genes as biomarkers for prostate cancer diagnosis and therapy.

Main Methods:

• Utilized cDNA library subtraction of prostate tumors and normal prostate tissue.
• Employed high-throughput microarray screening to analyze gene expression levels.
• Confirmed gene expression using Northern blot, real-time PCR (TaqMan), and immunohistochemistry.
• Predicted subcellular localization using the PSORT bioinformatic algorithm.

Main Results:

• Successfully identified three novel genes: P503S, P504S, and P510S.
• Demonstrated overexpression of these genes in prostate tumors and/or normal prostate tissues.
• Confirmed P503S, P504S, and P510S are predicted to be plasma membrane proteins.
• Established expression profiles through multiple validation techniques.

Conclusions:

• P503S, P504S, and P510S are significantly overexpressed in prostate cancer.
• These genes represent promising candidates for developing novel diagnostic and therapeutic strategies for prostate cancer.
• The identified genes warrant further investigation for their specific roles in prostate tumorigenesis.